Richard Entsuah

Summary

Affiliation: Wyeth Research
Country: USA

Publications

  1. ncbi request reprint Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, 3811 O Hara Street, Pittsburgh, PA 15213 2593, USA
    J Womens Health (Larchmt) 14:609-16. 2005
  2. ncbi request reprint Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs
    Charles B Nemeroff
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Biol Psychiatry 63:424-34. 2008
  3. ncbi request reprint Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
    A R Entsuah
    Wyeth Ayerst Research, Collegeville, PA 19426, USA
    J Clin Psychiatry 62:869-77. 2001
  4. ncbi request reprint Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine
    Richard Entsuah
    Global Clinical Biostatistics, Wyeth Ayerst Research, 500 Arcola Road, Collegeville, PA 19426, USA
    J Psychiatr Res 36:111-8. 2002
  5. ncbi request reprint A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder
    Mark Pollack
    Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114 2790, USA
    Psychopharmacology (Berl) 194:233-42. 2007
  6. ncbi request reprint A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
    Nicholas A DeMartinis
    University of Connecticut School of Medicine, Farmington, Conn, USA
    J Clin Psychiatry 68:677-88. 2007
  7. ncbi request reprint Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release
    James M Ferguson
    University of Utah School of Medicine, Psychiatry, Salt Lake City, UT 84103, USA
    J Clin Psychiatry 68:58-68. 2007
  8. ncbi request reprint Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo
    Charles Shelton
    University of Kentucky, Lexington, Kentucky, USA
    Int Clin Psychopharmacol 20:233-8. 2005
  9. ncbi request reprint Venlafaxine versus placebo in the preventive treatment of recurrent major depression
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London W13 8WH, England, UK
    J Clin Psychiatry 65:328-36. 2004
  10. ncbi request reprint Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression
    Stephen M Stahl
    The Neuroscience Education Institute, Carlsbad, California 92009, USA
    Biol Psychiatry 52:1166-74. 2002

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, 3811 O Hara Street, Pittsburgh, PA 15213 2593, USA
    J Womens Health (Larchmt) 14:609-16. 2005
    ..To investigate whether differences in antidepressant efficacy are moderated by an interaction of age and gender...
  2. ncbi request reprint Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs
    Charles B Nemeroff
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Biol Psychiatry 63:424-34. 2008
    ..To compare venlafaxine and selective serotonin reuptake inhibitors (SSRIs; fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram) in the treatment of depression...
  3. ncbi request reprint Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
    A R Entsuah
    Wyeth Ayerst Research, Collegeville, PA 19426, USA
    J Clin Psychiatry 62:869-77. 2001
    ..This investigation compared these patient subpopulations on the basis of remission and response rates associated with venlafaxine and selective serotonin reuptake inhibitor (SSRI) treatment...
  4. ncbi request reprint Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine
    Richard Entsuah
    Global Clinical Biostatistics, Wyeth Ayerst Research, 500 Arcola Road, Collegeville, PA 19426, USA
    J Psychiatr Res 36:111-8. 2002
    ..Quantifying efficacy and safety differences between drugs is difficult because rigorous statistical methods to assess benefit and risk simultaneously are lacking...
  5. ncbi request reprint A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder
    Mark Pollack
    Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114 2790, USA
    Psychopharmacology (Berl) 194:233-42. 2007
    ..Few randomized, placebo-controlled trials have evaluated the comparative efficacy and tolerability of more than one pharmacological agent for panic disorder...
  6. ncbi request reprint A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
    Nicholas A DeMartinis
    University of Connecticut School of Medicine, Farmington, Conn, USA
    J Clin Psychiatry 68:677-88. 2007
    ..This study evaluated the efficacy and safety of desvenlafaxine succinate extended-release in major depressive disorder (MDD)...
  7. ncbi request reprint Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release
    James M Ferguson
    University of Utah School of Medicine, Psychiatry, Salt Lake City, UT 84103, USA
    J Clin Psychiatry 68:58-68. 2007
    ..To compare the long-term efficacy of venlafaxine extended release (ER) with placebo in preventing panic disorder relapse in out-patient treatment responders...
  8. ncbi request reprint Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo
    Charles Shelton
    University of Kentucky, Lexington, Kentucky, USA
    Int Clin Psychopharmacol 20:233-8. 2005
    ..Remission was achieved earlier with venlafaxine and lasted throughout the remainder of the study. These results demonstrate that venlafaxine XR is more effective than fluoxetine/paroxetine for sustaining remission of depressive symptoms...
  9. ncbi request reprint Venlafaxine versus placebo in the preventive treatment of recurrent major depression
    Stuart A Montgomery
    Imperial College School of Medicine, PO Box 8751, London W13 8WH, England, UK
    J Clin Psychiatry 65:328-36. 2004
    ..Long-term efficacy and safety of prophylactic venlafaxine treatment were evaluated in outpatients with recurrent major depression...
  10. ncbi request reprint Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression
    Stephen M Stahl
    The Neuroscience Education Institute, Carlsbad, California 92009, USA
    Biol Psychiatry 52:1166-74. 2002
    ..The dual serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine is a dual reuptake inhibitor that may therefore offer greater efficacy than selective serotonin reuptake inhibitors (SSRIs)...
  11. ncbi request reprint A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects
    Richard Entsuah
    Clinical Biostatistics, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426, USA
    J Psychiatr Res 36:437-48. 2002
    ..Our data further suggest the subscales can predict the presence of remission. Given these findings, prudent use of these subscales may be appropriate, cost-effective, and informative...
  12. ncbi request reprint A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder
    Michael R Liebowitz
    Department of Psychiatry, Columbia University, New York, NY, USA
    J Clin Psychiatry 68:1663-72. 2007
    ..This study evaluated the efficacy and tolerability of desvenlafaxine succinate (desvenlafaxine) in the treatment of major depressive disorder (MDD)...